BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 32483414)

  • 1. Skipping of exon 10 in
    Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
    Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
    Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
    Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTBP1-mediated regulation of AXL mRNA stability plays a role in lung tumorigenesis.
    Cho CY; Chung SY; Lin S; Huang JS; Chen YL; Jiang SS; Cheng LC; Kuo TH; Lay JD; Yang YY; Lai GM; Chuang SE
    Sci Rep; 2019 Nov; 9(1):16922. PubMed ID: 31729427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTBP1 enhances exon11a skipping in Mena pre-mRNA to promote migration and invasion in lung carcinoma cells.
    Li S; Shen L; Huang L; Lei S; Cai X; Breitzig M; Zhang B; Yang A; Ji W; Huang M; Zheng Q; Sun H; Wang F
    Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):858-869. PubMed ID: 31075540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2.
    Yu-Ying C; Qian Z; Meng-Hui G; Lan F; Peng-Bo C; Gang-Qiao Z
    Yi Chuan; 2024 Jan; 46(1):46-62. PubMed ID: 38230456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA HOTTIP facilitates cell proliferation, invasion, and migration in osteosarcoma by interaction with PTBP1 to promote KHSRP level.
    Yao XY; Liu JF; Luo Y; Xu XZ; Bu J
    Cell Cycle; 2021 Feb; 20(3):283-297. PubMed ID: 33475442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy.
    Wang X; Li Y; Fan Y; Yu X; Mao X; Jin F
    J Cell Physiol; 2018 Nov; 233(11):8930-8939. PubMed ID: 29856478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
    Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
    Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer.
    Takahashi H; Nishimura J; Kagawa Y; Kano Y; Takahashi Y; Wu X; Hiraki M; Hamabe A; Konno M; Haraguchi N; Takemasa I; Mizushima T; Ishii M; Mimori K; Ishii H; Doki Y; Mori M; Yamamoto H
    Mol Cancer Ther; 2015 Jul; 14(7):1705-16. PubMed ID: 25904505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A miR-194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinoma.
    Kang H; Heo S; Shin JJ; Ji E; Tak H; Ahn S; Lee KJ; Lee EK; Kim W
    J Pathol; 2019 Nov; 249(3):395-408. PubMed ID: 31301177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alternative splicing of intersectin 1 regulated by PTBP1 promotes human glioma progression.
    Lan C; Zhang H; Wang K; Liu X; Zhao Y; Guo Z; Zhang N; Zhou Y; Gao M; Gu F; Ma Y
    Cell Death Dis; 2022 Sep; 13(9):835. PubMed ID: 36171198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation.
    Luo A; Lan X; Qiu Q; Zhou Q; Li J; Wu M; Liu P; Zhang H; Lu B; Lu Y; Lu W
    Cell Death Dis; 2022 Nov; 13(11):936. PubMed ID: 36344495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative microexon splicing by RBFOX2 and PTBP1 is associated with metastasis in colorectal cancer.
    Mochizuki Y; Funayama R; Shirota M; Kikukawa Y; Ohira M; Karasawa H; Kobayashi M; Ohnuma S; Unno M; Nakayama K
    Int J Cancer; 2021 Nov; 149(10):1787-1800. PubMed ID: 34346508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells.
    Sayed ME; Yuan L; Robin JD; Tedone E; Batten K; Dahlson N; Wright WE; Shay JW; Ludlow AT
    Oncogene; 2019 Apr; 38(16):2937-2952. PubMed ID: 30568224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis.
    Izaguirre DI; Zhu W; Hai T; Cheung HC; Krahe R; Cote GJ
    Mol Carcinog; 2012 Nov; 51(11):895-906. PubMed ID: 21976412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-scale remodeling of a repressed exon ribonucleoprotein to an exon definition complex active for splicing.
    Wongpalee SP; Vashisht A; Sharma S; Chui D; Wohlschlegel JA; Black DL
    Elife; 2016 Nov; 5():. PubMed ID: 27882870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.
    Jo YK; Roh SA; Lee H; Park NY; Choi ES; Oh JH; Park SJ; Shin JH; Suh YA; Lee EK; Cho DH; Kim JC
    Cancer Lett; 2017 Jan; 385():21-27. PubMed ID: 27836735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
    Takai T; Yoshikawa Y; Inamoto T; Minami K; Taniguchi K; Sugito N; Kuranaga Y; Shinohara H; Kumazaki M; Tsujino T; Takahara K; Ito Y; Akao Y; Azuma H
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma.
    Xu MZ; Chan SW; Liu AM; Wong KF; Fan ST; Chen J; Poon RT; Zender L; Lowe SW; Hong W; Luk JM
    Oncogene; 2011 Mar; 30(10):1229-40. PubMed ID: 21076472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and functional significance of CDC42 alternative splicing in ovarian cancer.
    He X; Yuan C; Yang J
    Oncotarget; 2015 Oct; 6(30):29651-63. PubMed ID: 26336992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.